Synapses were firing throughout the conference room in the Colket Translational Research Building as attendees at the 2017 Research Institute Scientific Symposium held May 2 learned about their colleagues' intriguing research endeavors. The four sessions' themes aligned smartly with the Research Institute's strategic planning process and overall mission of the Children's Hospital of Philadelphia.
This week we're all about getting smart in our highlights of research news from The Children's Hospital of Philadelphia. Getting smart in the approach to tackling childhood cancer means identifying strategies that will make a decade's progress in half the time - which is exactly the focus of the national Cancer Moonshot.
The research team concluded that early detection and gene therapy may offer the best results among infants diagnosed with Canavan disease. Canavan disease is a rare inherited neurological disorder with devastating effect. The lack of a specific enzyme, called aspartoacylase, causes the body's central nervous system to break down. The disease is usually fatal before a child reaches the teenage years.